Evolent Health Return on Tangible Equity 2014-2025 | EVH
Current and historical return on tangible equity values for Evolent Health (EVH) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Evolent Health Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-06-30 | $-0.19B | $-0.66B | 28.75% |
| 2025-03-31 | $-0.14B | $-0.68B | 22.40% |
| 2024-12-31 | $-0.09B | $-0.63B | 15.23% |
| 2024-09-30 | $-0.10B | $-0.61B | 16.89% |
| 2024-06-30 | $-0.11B | $-0.59B | 17.11% |
| 2024-03-31 | $-0.14B | $-0.62B | 22.24% |
| 2023-12-31 | $-0.14B | $-0.62B | 22.12% |
| 2023-09-30 | $-0.11B | $-0.62B | 19.87% |
| 2023-06-30 | $-0.08B | $-0.65B | 15.77% |
| 2023-03-31 | $-0.04B | $-0.65B | 11.83% |
| 2022-12-31 | $-0.02B | $-0.31B | 9.63% |
| 2022-09-30 | $-0.01B | $-0.32B | 11.31% |
| 2022-06-30 | $-0.03B | $-0.08B | 70.73% |
| 2022-03-31 | $-0.03B | $-0.09B | 180.82% |
| 2021-12-31 | $-0.04B | $-0.01B | -660.87% |
| 2021-09-30 | $-0.05B | $0.01B | -458.54% |
| 2021-06-30 | $-0.07B | $0.01B | -535.85% |
| 2021-03-31 | $-0.27B | $0.01B | -2171.43% |
| 2020-12-31 | $-0.34B | $0.01B | -5153.85% |
| 2020-09-30 | $-0.52B | $0.03B | -3002.90% |
| 2020-06-30 | $-0.51B | $0.01B | -2567.09% |
| 2020-03-31 | $-0.34B | $-0.01B | -1135.59% |
| 2019-12-31 | $-0.30B | $0.05B | -688.64% |
| 2019-09-30 | $-0.12B | $0.04B | -229.11% |
| 2019-06-30 | $-0.11B | $0.05B | -119.67% |
| 2019-03-31 | $-0.09B | $0.04B | -69.92% |
| 2018-12-31 | $-0.05B | $0.09B | -33.92% |
| 2018-09-30 | $-0.05B | $0.18B | -27.37% |
| 2018-06-30 | $-0.05B | $0.18B | -28.13% |
| 2018-03-31 | $-0.06B | $0.18B | -41.99% |
| 2017-12-31 | $-0.06B | $0.18B | -64.04% |
| 2017-09-30 | $-0.07B | $0.18B | -112.55% |
| 2017-06-30 | $-0.06B | $0.01B | -132.63% |
| 2017-03-31 | $-0.05B | $0.02B | -67.08% |
| 2016-12-31 | $-0.16B | $0.03B | -139.78% |
| 2016-09-30 | $-0.15B | $0.14B | -99.49% |
| 2016-06-30 | $-0.15B | $0.14B | -96.26% |
| 2016-03-31 | $0.22B | $0.15B | 136.65% |
| 2015-12-31 | $0.33B | $0.16B | 257.31% |
| 2015-09-30 | $0.33B | $0.16B | 379.31% |
| 2015-06-30 | $0.34B | $0.17B | 725.13% |
| 2015-03-31 | $-0.03B | $0.02B | -720.00% |
| 2014-12-31 | $-0.03B | $0.00B | 5200.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.134B | $2.555B |
| Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.991B | 53.84 |
| Tempus AI (TEM) | United States | $13.179B | 0.00 |
| Doximity (DOCS) | United States | $12.725B | 56.62 |
| Hims & Hers Health (HIMS) | United States | $9.572B | 78.43 |
| IRhythm Technologies (IRTC) | United States | $5.461B | 0.00 |
| Hinge Health (HNGE) | United States | $4.399B | 0.00 |
| Privia Health (PRVA) | United States | $2.828B | 209.46 |
| Inspire Medical Systems (INSP) | United States | $2.771B | 40.74 |
| Heartflow (HTFL) | $2.557B | 0.00 | |
| Phreesia (PHR) | United States | $1.884B | 0.00 |
| Enovis (ENOV) | United States | $1.766B | 9.34 |
| 10x Genomics (TXG) | United States | $1.744B | 0.00 |
| Omnicell (OMCL) | United States | $1.497B | 28.84 |
| Schrodinger (SDGR) | United States | $1.436B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 61.08 |
| Clover Health Investments (CLOV) | United States | $1.343B | 0.00 |
| Claritev (CTEV) | United States | $1.135B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.679B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.652B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.481B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 133.00 |
| Butterfly Network (BFLY) | United States | $0.405B | 0.00 |
| Carlsmed (CARL) | United States | $0.354B | 0.00 |
| TruBridge (TBRG) | United States | $0.300B | 52.53 |
| Outset Medical (OM) | United States | $0.247B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.239B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.234B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.213B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.195B | 0.00 |
| CapsoVision (CV) | United States | $0.175B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.168B | 0.00 |
| CareCloud (CCLD) | United States | $0.163B | 7.38 |
| American Well (AMWL) | United States | $0.111B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.077B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| Pulmonx (LUNG) | United States | $0.070B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| 111 (YI) | China | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.046B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Precipio (PRPO) | United States | $0.025B | 0.00 |
| PROFUSA (PFSA) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |